No Data
No Data
Axogen Processing Center (APC) Celebrates Its Opening With Ohio Leaders in Vandalia
ALACHUA, Fla. and TAMPA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft
AxoGen (AXGN) said Thursday it has started the rolling submission process for a biologics license application for Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograf
Express News | AxoGen Inc - Believe Procedural Timelines for Review Combined With Rolling Submission Process Will Allow for Approval Around Mid-2025
Express News | AxoGen Inc - Anticipate Bla Filing to Be Completed in Q3 of 2024
Express News | AxoGen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®